Top Markets
Coin of the day
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Classifica tra le azioni #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Prezzo delle azioni
$0.3479
Ultima sincronizzazione: 2024-08-21
Capitalizzazione di mercato
$94.92M
Variazione (1 giorno)
0.64%
Variazione (1 anno)
0.00%
Paese
US
Scambia Asensus Surgical, Inc. (ASXC)

Categoria

Utile per Asensus Surgical, Inc. (ASXC)
Utile nel Jun 2024 TTM: $-83.44M
Secondo gli ultimi rapporti finanziari di Asensus Surgical, Inc., gli utili attuali della società sono $-83.44M. Nel 2022, la società ha registrato un utile di $-75.24M, una diminuzione rispetto a agli utili del 2021, che erano di $-62.24M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Asensus Surgical, Inc. dal 2000 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $-83.44M 6.82%
2023 $-78.12M 3.82%
2022 $-75.24M 20.90%
2021 $-62.24M 2.32%
2020 $-60.83M -61.34%
2019 $-157.33M 141.47%
2018 $-65.15M -56.01%
2017 $-148.10M 18.00%
2016 $-125.50M 161.62%
2015 $-47.97M 27.41%
2014 $-37.65M 32.77%
2013 $-28.36M 83.84%
2012 $-15.43M 167.89%
2011 $-5.76M 8.58%
2010 $-5.30M 124.13%
2009 $-2.37M -54.37%
2008 $-5.19M 70.50%
2007 $-3.04M 1,390.69%
2006 $-204.00K -10.53%
2005 $-228.00K -48.65%
2004 $-444.00K -54.04%
2003 $-966.00K -82.05%
2002 $-5.38M -997.00%
2001 $600.00K -77.01%
2000 $2.61M 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$7.51B -9,101.35%
US
$5.15B -6,269.48%
US
$5.56B -6,766.83%
IE
$3.86B -4,727.11%
US
- -
DE